期刊文献+

喉鳞状细胞癌中P53和PTEN蛋白的表达及临床意义 被引量:6

Expressions of P53 and PTEN in laryngeal squamous cell carcinoma and their clinical significances
下载PDF
导出
摘要 目的 探讨喉鳞状细胞癌中P53、PTEN蛋白的表达及其与临床特征的关系。方法 采用免疫组化技术检测66例喉鳞癌组织和36例喉黏膜慢性炎症组织中P53、PTEN蛋白的表达。结果 P53、PTEN蛋白在66例喉鳞癌组织和36例喉黏膜慢性炎症组织中表达均存在统计学意义(P〈0.05)。66例喉鳞癌组织中,P53蛋白的表达水平在Ⅲ~Ⅳ期组高于Ⅰ~Ⅱ组(P〈0.05),淋巴结转移者高于无淋巴结转移者(P〈0.05);PTEN蛋白的表达水平Ⅰ~Ⅱ期组高于Ⅲ~Ⅳ期组(P〈0.05),高分化癌组高于中低分化癌组(P〈0.05),无淋巴结转移者高于有转移者(P〈0.05)。喉鳞癌组织中P53、PTEN蛋白两者表达有相关性(P〈0.05)。结论 PTEN蛋白的表达对预测喉鳞癌的预后有一定参考价值。 Objective To investigate the relation of expressions of P53 and PTEN with clinical histological characteristics and prognosis of laryngeal squamous cell carcinoma (LSCC). Methods The expressions of P53 and PTEN were examined with immunohistochemical staining in specimens from 66 cases of LSCC and 36 cases of laryngeal chronic inflammatory mucous membrane (LCIMM). Results The differences of expressions of P53 and PTEN between LSCC and LCIMM were statistically significant ( P〈0. 05). In LSCC the expressions of P53 protein in patients of stages Ⅲ-Ⅳ , with lymphatic metastasis were stronger than those of stages Ⅰ-Ⅱ ,without lymphatic metastasis respectively ( P〈0. 05) ; the expressions of PTEN protein in patients of stages Ⅰ-Ⅱ, well differentiation and without lymphatic metastasis were stronger than those of stages Ⅲ -Ⅳ, moderate to poor differentiation and with lymphatic metastasis respectively ( P 〈10.05). There was no significant correlation between P53 protein and PTEN protein in LSCC ( P〉0. 05). Conclusion The overexpression of P53 protein and lower expression of PTEN may play some important roles in the pathogenesis of LSCC.
出处 《中国耳鼻咽喉颅底外科杂志》 CAS 2007年第1期13-16,20,共5页 Chinese Journal of Otorhinolaryngology-skull Base Surgery
关键词 喉肿瘤 鳞状细胞 P53 FTEN 免疫组化 预后 Laryngeal Neoplasm Carcinoma, squarnous cell P53 PTEN Immunohistochemistry Prognosis
  • 相关文献

参考文献4

二级参考文献18

  • 1BoglerO,HuangHJ,KleihuesPetal.Thep53geneanditsroleinhumanbraintumors[].Glia.1995
  • 2KatoH,KatoS,KumabeTetal.Functionalevaluationofp53andPTENgenemutationsingliomas[].ClinCancerRes.2000
  • 3McCurrach ME,Connor TM,Knudson CM,et al.bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis[].Proceedings of the National Academy of Sciences of the United States of America.1997
  • 4Miyashita T,Harigai M,Hanada M,et al.Identification of a p53-dependent negative response element in the bcl-2 gene[].Cancer Research.1994
  • 5DaviesMP,GibbsFE,HalliwellN,etal.MutationinthePTEN/MMAC1geneinarchivallowgradeandhighgradegliomas[].British Journal of Cancer.1999
  • 6Ali IU,Schriml LM,Dean M.Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity[].Journal of the National Cancer Institute.1999
  • 7Dijkers PF,Medema RH,Pals C, et al.Forkhead transcription factor FKHR-L1 modulates cytokine-dependenttranscriptional regulation of p27 (KIP1)[].Molecular and Cellular Biology.2000
  • 8Davies MA,Koul D,Dhesi H,et al.Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN[].Cancer Research.1999
  • 9Stambolic V,Macpherson D,Sas D,et al.Regulation of PTEN transcription by P53[].Molecular Cell.2001
  • 10Singh B,Reddy PG,Goberdhan A,et al.p53 regulates cell sur-vival by inhibiting PIK3CA in squamous cell carcinomas[].Genes and Development.2002

共引文献49

同被引文献65

引证文献6

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部